Literature DB >> 3355613

A little more information about aggravation of probucol-induced HDL-reduction by clofibrate.

S Yokoyama1, A Yamamoto, T Kurasawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3355613     DOI： 10.1016/0021-9150(88)90114-1

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  7 in total

1.  Probucol ameliorates the development of nonalcoholic steatohepatitis in rats fed high-fat diets.

Authors:  Rong Wu; Wei Zhang; Bo Liu; Jing Gao; Xiao-Qiu Xiao; Feng Zhang; Hua-Mei Zhou; Xiao-Ling Wu; Xia Zhang
Journal:  Dig Dis Sci       Date:  2012-08-10       Impact factor: 3.199

Review 2.  Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.

Authors:  M M Buckley; K L Goa; A H Price; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

3.  Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis.

Authors:  Reijiro Arakawa; Maki Tsujita; Noriyuki Iwamoto; Chisato Ito-Ohsumi; Rui Lu; Chen-Ai Wu; Kenji Shimizu; Tomoji Aotsuka; Hashime Kanazawa; Sumiko Abe-Dohmae; Shinji Yokoyama
Journal:  J Lipid Res       Date:  2009-05-20       Impact factor: 5.922

4.  High-density lipoprotein and apolipoprotein A-I deficiency induced by combination therapy with probucol and bezafibrate.

Authors:  K Saku; B Zhang; S Jimi; H Bai; K Hirata; N Sasaki; R Liu; K Arakawa
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 5.  Current Status of Familial LCAT Deficiency in Japan.

Authors:  Masayuki Kuroda; Hideaki Bujo; Koutaro Yokote; Takeyoshi Murano; Takashi Yamaguchi; Masatsune Ogura; Katsunori Ikewaki; Masahiro Koseki; Yasuo Takeuchi; Atsuko Nakatsuka; Mika Hori; Kota Matsuki; Takashi Miida; Shinji Yokoyama; Jun Wada; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2021-04-18       Impact factor: 4.928

6.  Selective Correction of Genotype Yield by Probucol in HDL-Deficient Mice Propagation.

Authors:  Maki Tsujita; Nobukatsu Akita; Tomo Yokota; Fumihiko Kobayashi; Shinji Yokoyama
Journal:  J Atheroscler Thromb       Date:  2019-05-14       Impact factor: 4.928

7.  High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells.

Authors:  Anouar Hafiane; Annalisa Ronca; Robert S Kiss; Elda Favari
Journal:  Front Cardiovasc Med       Date:  2022-04-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.